Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Arvinas, Inc. (ARVN)
On May 1, 2025, Arvinas and its partner Pfizer announced that they would discontinue development of vepdegestrant, an oral SERD for HR-positive breast cancer. The move eliminated two planned Phase 3 studies, following the termination of VERITAC-3 in January. According to The Fly, a financial news platform, Oppenheimer & Co. 'was surprised by the announcement' and questioned whether 'Arvinas' management isn't telling us the whole story.' Arvinas had repeatedly pointed to clinical progress for vepdegestrant and the drug's commercial opportunity, leaving investors caught off guard by the abrupt pivot. On this news, the price of Arvinas shares declined by $2.39 per share, or approximately 25%, from $9.62 per share on April 30, 2025, to close at $7.23 on May 1, 2025.
If you purchased or otherwise acquired Arvinas securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests with respect to these matters without any cost to you.
[CONTACT FORM]
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
JPMorgan eyes new research frontier with coverage of private firms, source says
By Nupur Anand and Manya Saini (Reuters) -JPMorgan Chase has begun publishing research notes on prominent private companies transforming industries, a person familiar with the matter told Reuters on Friday. With many industry-leading private companies delaying public listings, they are attracting a growing share of investor capital, prompting institutional investors to track them more closely at earlier stages. Companies such as ChatGPT-maker OpenAI, Elon Musk's SpaceX and TikTok-parent Bytedance now hold valuations that rival or surpass several major S&P 500 firms, blurring the distinction between public and private market influence. The largest U.S. lender released its first report on OpenAI, the company that spurred Wall Street's AI gold rush, according to an internal memo seen by Reuters. Unlike traditional research notes, these brokerage reports will not feature estimates, price targets or ratings, Hussein Malik, head of global research said in the memo, which highlighted AI and software as core areas for private company coverage. "Private companies are becoming increasingly relevant to various industries, especially in the new economy space," Malik said. "The goal of this offering is to support our investor clients by providing structured information and tracking, offering deeper insights into key disruptors and their impact on the sectors in which they operate." Institutional investors are increasingly focused on private company research and investment opportunities as these firms develop technologies that influence mature sectors, the source added. Nearly 1,500 private startups have achieved unicorn status, having raised funding at valuations above $1 billion, according to PitchBook's tracker. North America leads globally with over 1,000 unicorns, collectively valued at nearly $4 trillion. As private companies play a growing role in transforming legacy industries, Wall Street is adjusting to rising demand for insights into these influential firms, reflecting a shift in how market power is assessed. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 minutes ago
- Yahoo
GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee
NEW YORK, United States, July 18th, 2025, ChainwireGSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) ('MEI'), in which it will serve as both strategic advisor and digital asset treasury manager. The $100 million private investment in public equity (PIPE) into MEI represents a significant step toward institutionalizing Litecoin as a treasury asset. GSR will work closely with Litecoin (LTC) creator Charlie Lee, who brings deep technical credibility and a long-term perspective on Litecoin's evolution, with support from the Litecoin Foundation. Lee and a GSR appointee will also join MEI's Board of Directors. This initiative follows MEI's previously announced review of strategic alternatives and reflects its new mission in alignment with both the Litecoin Foundation and GSR's digital asset management platform. 'Litecoin has consistently delivered a stable, low-cost, and accessible network for over a decade,' said Charlie Lee, creator of Litecoin. 'With leading global transaction volume on platforms like BitPay, Litecoin is trusted by users and integrated across retail and payments. This partnership with GSR and MEI brings that utility and mission into an institutional setting for the first time.' MEI's leadership is driving this strategic shift, viewing the partnership as a bridge between public markets and crypto-native innovation. With GSR serving as asset manager and execution partner, MEI will be well-positioned to manage LTC as a treasury asset. 'This initiative represents the first time a public company is aligning its treasury strategy with Litecoin at an institutional level,' said Joshua Riezman, US Chief Strategy Officer, GSR. 'It reflects rising institutional confidence in LTC's credibility, resilience, and regulatory clarity.' 'There is already meaningful institutional interest in Litecoin, but few mechanisms exist to access it in a secure and structured way,' said Quynh Ho, Head of Venture Investment, GSR. 'This investment is designed to close that gap by enabling access to an asset with remarkable staying power.' With GSR as an investor, strategic advisor, and asset manager, the collaboration creates potential momentum for LTC's future growth in decentralized finance. GSR's broader involvement in the space, including the incubation of the Polygon-based protocol Katana, highlights its expertise in supporting emerging ecosystems. Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto venture capital firms and infrastructure providers, including Mozayyx, Parafi, HiveMind, Primitive, RLH Capital, Delta Blockchain, and CoinFund, among other financial institutions. GSR continues to invest in the broader digital asset ecosystem, offering capital solutions, liquidity, and strategic advisory services to partners at all stages of growth. About GSR GSR is crypto's capital markets partner, delivering market-making, institutional-grade OTC trading, and strategic venture backing to founders and institutions. With more than a decade of experience, we provide strategic guidance, market intelligence, and access to a global network to help teams scale. Users can follow GSR on X or visit for more Public RelationsHaley | © Copyright 2025 All rights reserved Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 minutes ago
- Yahoo
JPMorgan Adds Private Firms to Research Starting With OpenAI
(Bloomberg) -- JPMorgan Chase & Co. is expanding research coverage to private companies in the Wall Street bank's latest effort to capitalize on the rapidly growing field. The Dutch Intersection Is Coming to Save Your Life Mumbai Facelift Is Inspired by 200-Year-Old New York Blueprint Advocates Fear US Agents Are Using 'Wellness Checks' on Children as a Prelude to Arrests LA Homelessness Drops for Second Year Manhattan, Chicago Murder Rates Drop in 2025, Officials Say The coverage will begin with sectors where private companies play a bigger role in shaping industry dynamics and innovations, such as AI and software, according to a person familiar with the matter. In its first move, the bank launched coverage on OpenAI on Friday. Unlike traditional equity research on public firms, the new offering won't include ratings, price targets or estimates on private companies, Hussein Malik, JPMorgan's head of global research, said in an internal memo seen by Bloomberg. The goal is to provide investor clients with structured information and tracking, he said. 'Private companies are increasingly pivotal in shaping the growth and outlook of industries,' Malik said in an external note to clients. 'Understanding their impact is and will remain crucial for both public and private market investors to make informed investment decisions.' Professional investors have been increasingly turning to private firms, which are drawing an ever-larger share of capital. Elon Musk's SpaceX hit a valuation of $350 billion last year, a number that would place it among the 25 largest companies in the S&P 500. At least three of Bytedance Ltd.'s major investors have marked up the TikTok-owner's valuation to more than $400 billion, Bloomberg reported in February. Nearly 1,500 startups across the world have a valuation of $1 billion or more, according to data by PitchBook. These firms typically fall through the cracks of Wall Street analysts due to limited financial information and a focus on public markets, though several banks are ramping up their coverage. For instance, UBS Group AG started private company research in mid-2022, and its analysts have published profiles on over 1,300 firms across sectors, according to a spokesperson for the bank. 'I think the convergence of public-private is really important for the investment community,' Marta Norton, chief investment strategist at Empower, said in an interview with Bloomberg TV. 'For us to really understand the dynamics of the public market we have to have a better understanding of the private market.' In their first report on OpenAI, JPMorgan analysts Brenda Duverce and Lula Sheena said it would be difficult for any chatbot maker to maintain a sustained competitive edge on large language models. With profitability not expected for the startup until 2029, 'investor expectations may be tested,' they wrote. JPMorgan has one of the biggest research arms on Wall Street, with more than 800 analysts covering thousands of companies around the world. The company produces around 100,000 pieces of research every year, according to its website. The bank earlier this week reported a surprise rise in investment-banking fee income, signaling what may be the start of a dealmaking rebound after widespread hesitation tied to US tariff policies. While JPMorgan has earmarked billions of dollars for direct lending to companies that shun traditional bank loans or public markets, Chief Executive Officer Jamie Dimon said on this week's earnings call that 'you may have seen peak private credit.' --With assistance from Ed Ludlow and Paayal Zaveri. (Updates with UBS's private company coverage and investor comments in seventh and eighth paragraphs.) What the Tough Job Market for New College Grads Says About the Economy How Starbucks' CEO Plans to Tame the Rush-Hour Free-for-All Godzilla Conquered Japan. Now Its Owner Plots a Global Takeover A Rebel Army Is Building a Rare-Earth Empire on China's Border Why Access to Running Water Is a Luxury in Wealthy US Cities ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
